Potent, cell permeable, irreversible, and selective inhibitor of EGF receptor (EGFR) tyrosine kinase activity (IC50=700pM). Antitumor agent in vivo.
Product Specification
| Alternative Name: | 4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline |
| |
| Formula: | C17H13BrN4O |
| |
| MW: | 369.2 |
| |
| CAS: | 194423-15-9 |
| |
| Purity: | ≥95% (HPLC) |
| |
| Appearance: | Yellow to orange solid. |
| |
| Solubility: | Soluble in DMSO (200 mg/ml). |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Protect from light. Keep under inert gas. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor: D.W. Fry, et al.; PNAS
95, 12022 (1998),
Abstract;
Full Text
